December 22, 2015 (340B Health) – 340B critics are building momentum on Capitol Hill and 2016 will be a challenging year with potential for harmful changes to the program. Much of the focus over the past year has been on Medicare Part B reimbursement to 340B hospitals with reports by the Government Accountability Office and the Department of Health and Human Services Office of Inspector General. MedPAC, the commission that advises Congress on Medicare, is considering recommending reimbursement cuts that would undermine your efforts to serve our most vulnerable.
Meanwhile, the drug industry and their allies continue their aggressive efforts to mischaracterize the 340B program.  Congressional hearings and harmful legislation could be on the table again in 2016.
Please join us January 20 to get up-to-date information on what’s in store for the coming year, the best strategies for engaging lawmakers to become 340B champions, and specific opportunities to work together to safeguard 340B.
INTENDED AUDIENCE: This event is exclusively for 340B Health member and prospective member hospitals. Recommended for C-level executives, government relations specialists, pharmacy directors, 340B managers and others involved in the 340B program.
Dolores Dunn, Vice President, Government Relations, 340B Health
Kathryn DiBitetto, Director, Government Relations, 340B Health
Liam Steadman, Manager, Government Relations, 340B Health
Amanda Smith, Manager, Grassroots and Advocacy, 340B Health
Click here to read more or register for the complimentary webinar.

Subscribe To Our Newsletter

Join our mailing list to receive the latest news and updates from our team.

You have Successfully Subscribed!